Next Article in Journal
RNA-Loaded Nanoparticles for Targeted Lung Delivery
Previous Article in Journal
Guideline-Directed Medical Therapy Intensity, Ventricular Remodeling, and Clinical Outcomes After Acute Myocardial Infarction: A Single-Center Real-World Retrospective Cohort Study
Previous Article in Special Issue
Microbiome-Based Therapies in Ulcerative Colitis: Mechanisms, Clinical Evidence, and a Precision-Medicine Framework
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 14
Issue 5
10.3390/biomedicines14051068
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (3rd Edition) †

by
Dingpei Long
1,2,* and
Junsik J. Sung
3,4,*
1
State Key Laboratory of Resource Insects, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400715, China
2
Digestive Disease Research Group, Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA
3
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21250, USA
4
Department of Pharmaceutical and Administrative Sciences, College of Pharmacy and Health Sciences, Western New England University, Springfield, MA 01119, USA
*
Authors to whom correspondence should be addressed.
†
This article belongs to the Special Issue Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (3rd Edition).
Biomedicines 2026, 14(5), 1068; https://doi.org/10.3390/biomedicines14051068
Submission received: 24 April 2026 / Accepted: 6 May 2026 / Published: 8 May 2026
(This article belongs to the Special Issue Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (3rd Edition))
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The first editorial in this series approached inflammatory bowel disease (IBD) predominantly from the perspective of pathophysiology and therapeutic innovation [...]

Share and Cite

MDPI and ACS Style

Long, D.; Sung, J.J. Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (3rd Edition). Biomedicines 2026, 14, 1068. https://doi.org/10.3390/biomedicines14051068

AMA Style

Long D, Sung JJ. Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (3rd Edition). Biomedicines. 2026; 14(5):1068. https://doi.org/10.3390/biomedicines14051068

Chicago/Turabian Style

Long, Dingpei, and Junsik J. Sung. 2026. "Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (3rd Edition)" Biomedicines 14, no. 5: 1068. https://doi.org/10.3390/biomedicines14051068

APA Style

Long, D., & Sung, J. J. (2026). Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches (3rd Edition). Biomedicines, 14(5), 1068. https://doi.org/10.3390/biomedicines14051068

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop